Engaging With International Carcinogen Evaluations

Law360 (November 14, 2019, 4:55 PM EST) -- This July, the International Agency for Research on Cancer, or IARC, released its 2020-2024 priority list for evaluation.[1] Defense-oriented attorneys and corporations should be aware of the list and begin preparing for eventual evaluations by IARC working groups.

What Is IARC?

IARC is a branch of the World Health Organization located in Lyon, France. Tasked by the WHO with evaluating potential causes of cancer, IARC conducts hazard evaluations of suspected carcinogens two to three times a year.

The results of these evaluations are published in IARC monographs — summary publications that discuss the existing literature, and then apply a cancer classification...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS